Prescription patterns of antihypertensive drugs in a community-health centre in Mexico. A drug utilization study

30/11/2014
11/02/2019
EU PAS number:
EUPAS8086
Study
Finalised
Study identification

EU PAS number

EUPAS8086

Study ID

27991

Official title and acronym

Prescription patterns of antihypertensive drugs in a community-health centre in Mexico. A drug utilization study

DARWIN EU® study

No

Study countries

Mexico

Study description

In 2012, the National Health and Nutrition Survey reported a prevalence of hypertension in 31.5% of Mexico’s adult population, this rate has increased during the last few years, antihypertensive drug consumption has also increased. Whether this consumption is adequate to the current hypertension prevalence and current guidelines is still unknown. In this context, it is intended to know antihypertensive drugs’ prescription patterns, and to assess blood pressure control determinants in Mexico. For the purpose, a retrospective survey is carried out in a community-health centre in Mexico City. Medical records are reviewed to identify those corresponding to hypertension diagnosed patients. All relevant information is retrieved, particular attention is paid to co-morbidities and medications. The adequacy of actual treatment to the current official Mexican guidelines will be evaluated.

Study status

Finalised
Research institutions and networks

Institutions

NA

Contact details

Juan Molina

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

UNAM
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable